Impact of body mass index on 90-day warfarin requirements: a retrospective chart review
Background: Rates of obesity continue to rise worldwide as evidenced in the 2017 Centers for Disease Control and Prevention (CDC) report that indicated over 35% of United States (US) citizens are obese, with Louisiana ranked as the fifth most obese state in America. Since large clinical trials tend...
Main Authors: | Bolanle M. Soyombo, Ashley Taylor, Christopher Gillard, Candice Wilson, Janel Bailey Wheeler |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-06-01
|
Series: | Therapeutic Advances in Cardiovascular Disease |
Online Access: | https://doi.org/10.1177/17539447211012803 |
Similar Items
-
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
by: Cavalcante Joao, et al.
Published: (2008-06-01) -
Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation
by: Lone Rasmussen, et al.
Published: (2010-12-01) -
The Influence of Ethnicity on Warfarin Dosage Requirements in the Chilean Population
by: Valeska Subiabre, MsCs, et al.
Published: (2015-12-01) -
Genetic factors affecting warfarin dose requirements and clearance
by: King, Barry Philip
Published: (2005) -
Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review
by: Campbell Glenda, et al.
Published: (2008-07-01)